A single animal can express several cationic antimicrobial peptides with different sequences and structures. We demonstrate that mammalian peptides from different structural classes frequently show synergy with each other and selectively show synergy with human lysozyme.
not addressed synergy by using the well-established methods developed by clinical microbiologists, namely, checkerboard titration.
In this paper, we examine the synergy of peptides representing each of the structural classes found in mammals against four of the more serious pathogenic bacteria in our society. In addition, we perform a limited study to examine if such synergy can also be observed between these peptides and the moderately cationic innate defense protein lysozyme.
Four of the peptides were synthesized at the University of British Columbia's Nucleic Acid and Protein Sequencing Facility using tert-butoxycarbonyl chemistry and were purified by reversed-phase high-pressure liquid chromatography. These were the ␤-hairpin pig neutrophil peptide protegrin-1, the ␣-helical human peptide LL-37, the loop-structured bovine neutrophil peptide bactenecin, and the extended-structure bovine neutrophil peptide indolicidin. The disulfide bonds of protegrin and bactenecin were formed by oxidation and confirmed by matrix-assisted laser desorption ionization mass spectrometry as previously described (10) . The human ␤-defensin peptide HNP-1 was a kind gift from Bob Lehrer and Tom Ganz at the University of California at Los Angeles. Human lysozyme was purchased from Calbiochem (La Jolla, Calif.). The bacterial strains used included Pseudomonas aeruginosa PAO1 strain H103, Escherichia coli strain HB101, a methicillin-resistant Staphylococcus aureus (MRSA) strain, SAP0017, and Enterococcus faecalis ATCC 29212 (14) . They were cultured on Mueller-Hinton broth, solidified when necessary with Bacto Agar (Sigma Chemical Co., St. Louis, Mo). MIC assays and checkerboard titrations were performed using the modified microtiter dilution assay (1, 11, 14) .
The peptides examined showed only modest activities (e.g., relative to the best synthetic variants [12] ) against the four tested bacteria, with MICs ranging from 3.1 to 64 g/ml (Table  1) . HNP-1 and human lysozyme were not active against the gram-negative bacterium P. aeruginosa but readily killed the gram-positive bacterium E. faecalis. It should be noted, however, that this represents a very stringent test of antibacterial activity, in that Mueller-Hinton medium has a high ionic strength that can inhibit the action of such peptides. Indeed, in other assays employing dilute buffers, much more impressive activities can be observed (6) . However we employed Mueller-Hinton medium because it is considered to give MICs that are clinically meaningful (i.e., equivalent to activity in the human host) for cationic antibiotics such as the aminoglycosides.
Synergy was measured by checkerboard titrations (1), in which one peptide is diluted along the rows of a microtiter tray and the other is diluted along the columns. In this method, one is looking for a reduction in the MIC of each compound in the presence of the other. The result is expressed as the fractional inhibitory concentration (FIC) index, which is assessed as follows: Table 2 describes the results obtained with these peptides. In general, we observed synergy (FIC Ͻ 0.5) for several combinations of peptides in P. aeruginosa (three of six combinations), E. coli (four of six combinations), and E. faecalis (two of six combinations) but not in any instance with MRSA. The best peptide in combination was protegrin, which showed synergy with most peptides against most bacteria. We also examined the synergies of these peptides with the human neutrophil defensin HNP-1, although the limited availability of this peptide (which has three disulfide bonds and is very difficult to synthesize) reduced the scope of these experiments to two strains of bacteria and a single concentration of HNP-1. No synergy was observed with 25 g of HNP-1/ml and any peptide against P. aeruginosa. However, since we could not measure an MIC for this bacterium, we did not know what multiple of the MIC was represented by 25 g/ml and thus whether there was any possibility of seeing synergy. With E. faecalis we again failed to observe synergy, even though an MIC could be measured. Consistent with this, Levy et al. failed to observe synergy between de-fensins and a peptide, P15a (7) . Nevertheless, our results overall were consistent with the conclusion that peptide-peptide synergy does occur and is peptide specific.
We also examined the synergy of peptides with human lysozyme against P. aeruginosa and E. faecalis (again, our experiments were somewhat constrained by the high cost of human lysozyme). Human lysozyme by itself is poorly antimicrobial against wild-type P. aeruginosa strains under the conditions tested here, causing approximately 90% killing in 60 min (15) but not demonstrating a definite MIC. A single concentration of lysozyme, 25 g/ml, consistently reduced the MICs of protegrin and bactenecin by twofold but had no effect on the MICs of indolicidin, LL-37 (Table 3) , or HNP-1 (data not shown). It is possible that better synergy would have been observed if higher lysozyme concentrations were available, since we have observed synergy of many peptides with hen egg white lysozyme, which is relatively inexpensive and thus far more available (R. Hancock, unpublished data). In contrast, lysozyme showed higher natural activity and good synergy with two peptides against E. faecalis (Table 3) , with protegrin leading the way. In checkerboard titrations, MICs of protegrin and lysozyme were lowered from 16 and 6.3 g/ml alone to 4 and 0.39 g/ml, respectively, in combination.
Of the peptides studied in detail, only indolicidin and bactenecin from cattle actually coexist in nature. A major reason that we chose the studied peptides was that information on the types of peptides in any given species remains quite fragmentary, with defensins as the major structural type identified in mammals (3, 5) . Therefore, in this study we chose peptides primarily to represent the individual structural classes, which differ maximally from one another. It is thus an assumption here that peptides of given structural classes, regardless of their mammalian origin, will act in similar ways. Consistent with this, we have observed synergy similar to that observed with LL-37 with an insect-derived ␣-helical peptide (R. Hancock, unpublished observations).
Together, these data are consistent with the proposal that antimicrobial peptides demonstrate synergy with each other and with lysozyme in a peptide-specific manner. It is assumed that this reflects the cooperative interactions of the peptides with the outer membranes of gram-negative bacteria and/or cooperative interaction with lipid bilayers in general (8, 15) . We conclude, therefore, that given the substantial diversity of peptides in any given location in the host, synergistic interactions are an important determinant of the overall effectiveness of the peptides. 
